Share Price and Basic Stock Data
Last Updated: January 17, 2026, 12:28 pm
| PEG Ratio | -11.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Shalby Ltd, operating within the Hospitals & Medical Services sector, reported a current share price of ₹182 and a market capitalization of ₹1,964 Cr. The company recorded impressive revenue growth, with sales rising from ₹699 Cr in FY 2022 to ₹805 Cr in FY 2023, and projected revenues of ₹934 Cr for FY 2024 and ₹1,087 Cr for FY 2025. Quarterly sales figures also reflect a positive trend, with revenues reaching ₹237.98 Cr in September 2023 and further increasing to ₹296.43 Cr by June 2025. This growth trajectory indicates an upward demand for healthcare services, positioning Shalby to capitalize on the expanding healthcare market in India. The company’s operating profit margin (OPM) stood at 14.58%, suggesting effective cost management amidst rising operational expenses. Overall, Shalby’s revenue trends point towards a robust business model capable of capturing market share in a competitive landscape.
Profitability and Efficiency Metrics
Shalby Ltd’s profitability metrics reveal challenges despite its revenue growth. The net profit for FY 2025 is projected to be a mere ₹2 Cr, a significant decline from ₹68 Cr in FY 2023. The company’s operating profit margin (OPM) has fluctuated, recorded at 12% in FY 2025, down from 17% in FY 2023. The interest coverage ratio, which stood at 4.14x, indicates that Shalby can cover its interest obligations, though it reflects a decrease compared to previous years. The return on equity (ROE) is low at 0.62%, highlighting inefficiencies in generating profit from shareholders’ equity. The cash conversion cycle (CCC) is notably high at 698 days, suggesting potential liquidity issues and inefficiencies in managing operational cash flows. These profitability and efficiency concerns warrant attention as they may hinder long-term growth and investor confidence.
Balance Sheet Strength and Financial Ratios
Shalby Ltd’s balance sheet exhibits a mixed picture of financial health. The company reported total borrowings of ₹535 Cr against reserves of ₹895 Cr, indicating a manageable debt-to-equity ratio of 0.43. This suggests that Shalby is not overly leveraged, providing some stability. However, the declining trend in net profit and the high cash conversion cycle raises concerns about operational efficiency. The current ratio stood at 1.45, reflecting a solid liquidity position, while the quick ratio of 0.74 indicates a tighter cash position when accounting for current liabilities. The company’s book value per share is ₹92.31, which, with a price-to-book value ratio of 2.15x, suggests that the stock may be overvalued compared to its net asset value. These financial ratios highlight both strengths in liquidity and concerns regarding profitability, necessitating strategic management to enhance operational performance.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Shalby Ltd indicates a strong promoter holding of 74.33%, which reflects confidence in the company’s long-term prospects. Institutional investment is limited, with foreign institutional investors (FIIs) holding 4.63% and domestic institutional investors (DIIs) at 0.19%. Public ownership stands at 20.18%, showing a moderate level of retail investor engagement. The number of shareholders increased to 53,784, suggesting a growing interest in the company despite its recent profitability challenges. The promoter stake has remained stable, indicating their commitment, while the marginal fluctuations in FII and DII holdings suggest cautious optimism among institutional investors. This shareholding structure may provide a buffer against volatility but also highlights the need for improved financial performance to attract broader institutional interest.
Outlook, Risks, and Final Insight
Shalby Ltd’s outlook is contingent on addressing its profitability and operational efficiency issues. While the company has demonstrated strong revenue growth, the declining net profit and high cash conversion cycle pose significant risks. Additionally, the healthcare sector’s competitive nature and regulatory challenges could affect future performance. Strengths include a solid promoter holding and a manageable debt level, which can support strategic initiatives. If Shalby can enhance its operational efficiencies and profitability metrics, it may regain investor confidence and improve its market position. Conversely, failure to address these challenges could lead to diminished investor interest and potential financial instability. The company must focus on optimizing operations and financial management to realize its growth potential in the evolving healthcare landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 45.6 Cr. | 136 | 187/120 | 9.31 | 117 | 2.57 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 23.3 Cr. | 22.2 | 33.8/15.5 | 24.3 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 10.8 Cr. | 10.5 | 20.5/7.08 | 121 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 108 Cr. | 57.7 | 98.7/55.2 | 23.9 | 18.3 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 19.4 Cr. | 3.60 | 6.94/3.40 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 26,030.64 Cr | 690.98 | 90.24 | 93.18 | 0.34% | 15.48% | 14.81% | 9.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 201.80 | 202.46 | 198.98 | 235.49 | 237.98 | 216.05 | 244.23 | 278.89 | 267.54 | 275.63 | 264.89 | 296.43 | 285.43 |
| Expenses | 164.73 | 168.65 | 173.32 | 192.36 | 185.26 | 173.73 | 205.37 | 233.68 | 234.89 | 241.72 | 244.05 | 254.90 | 243.82 |
| Operating Profit | 37.07 | 33.81 | 25.66 | 43.13 | 52.72 | 42.32 | 38.86 | 45.21 | 32.65 | 33.91 | 20.84 | 41.53 | 41.61 |
| OPM % | 18.37% | 16.70% | 12.90% | 18.32% | 22.15% | 19.59% | 15.91% | 16.21% | 12.20% | 12.30% | 7.87% | 14.01% | 14.58% |
| Other Income | 5.31 | 4.19 | 9.18 | 4.53 | 5.38 | 4.52 | 4.99 | 9.70 | 7.16 | 5.42 | 5.32 | 7.01 | 4.48 |
| Interest | 1.79 | 2.67 | 2.84 | 2.75 | 3.17 | 3.63 | 6.47 | 8.12 | 9.26 | 10.66 | 10.67 | 9.37 | 9.65 |
| Depreciation | 11.90 | 11.79 | 12.81 | 11.94 | 12.30 | 12.40 | 15.60 | 16.37 | 16.84 | 16.32 | 16.23 | 16.52 | 17.37 |
| Profit before tax | 28.69 | 23.54 | 19.19 | 32.97 | 42.63 | 30.81 | 21.78 | 30.42 | 13.71 | 12.35 | -0.74 | 22.65 | 19.07 |
| Tax % | 35.83% | 35.09% | 27.57% | 36.85% | 35.30% | 38.14% | 26.35% | 51.55% | 82.71% | 124.21% | 1,547.30% | 66.09% | 61.88% |
| Net Profit | 18.40 | 15.28 | 13.90 | 20.82 | 27.57 | 19.06 | 16.04 | 14.74 | 2.36 | -2.99 | -12.19 | 7.68 | 7.28 |
| EPS in Rs | 1.70 | 1.42 | 1.29 | 1.93 | 2.55 | 1.77 | 1.54 | 1.45 | 0.31 | -0.17 | -1.02 | 0.83 | 0.78 |
Last Updated: December 29, 2025, 5:00 am
Below is a detailed analysis of the quarterly data for Shalby Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 285.43 Cr.. The value appears to be declining and may need further review. It has decreased from 296.43 Cr. (Jun 2025) to 285.43 Cr., marking a decrease of 11.00 Cr..
- For Expenses, as of Sep 2025, the value is 243.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 254.90 Cr. (Jun 2025) to 243.82 Cr., marking a decrease of 11.08 Cr..
- For Operating Profit, as of Sep 2025, the value is 41.61 Cr.. The value appears strong and on an upward trend. It has increased from 41.53 Cr. (Jun 2025) to 41.61 Cr., marking an increase of 0.08 Cr..
- For OPM %, as of Sep 2025, the value is 14.58%. The value appears strong and on an upward trend. It has increased from 14.01% (Jun 2025) to 14.58%, marking an increase of 0.57%.
- For Other Income, as of Sep 2025, the value is 4.48 Cr.. The value appears to be declining and may need further review. It has decreased from 7.01 Cr. (Jun 2025) to 4.48 Cr., marking a decrease of 2.53 Cr..
- For Interest, as of Sep 2025, the value is 9.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.37 Cr. (Jun 2025) to 9.65 Cr., marking an increase of 0.28 Cr..
- For Depreciation, as of Sep 2025, the value is 17.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.52 Cr. (Jun 2025) to 17.37 Cr., marking an increase of 0.85 Cr..
- For Profit before tax, as of Sep 2025, the value is 19.07 Cr.. The value appears to be declining and may need further review. It has decreased from 22.65 Cr. (Jun 2025) to 19.07 Cr., marking a decrease of 3.58 Cr..
- For Tax %, as of Sep 2025, the value is 61.88%. The value appears to be improving (decreasing) as expected. It has decreased from 66.09% (Jun 2025) to 61.88%, marking a decrease of 4.21%.
- For Net Profit, as of Sep 2025, the value is 7.28 Cr.. The value appears to be declining and may need further review. It has decreased from 7.68 Cr. (Jun 2025) to 7.28 Cr., marking a decrease of 0.40 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.78. The value appears to be declining and may need further review. It has decreased from 0.83 (Jun 2025) to 0.78, marking a decrease of 0.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:40 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 259 | 275 | 290 | 324 | 378 | 462 | 487 | 431 | 699 | 805 | 934 | 1,087 | 1,122 |
| Expenses | 196 | 207 | 235 | 252 | 299 | 379 | 404 | 342 | 577 | 667 | 755 | 952 | 984 |
| Operating Profit | 63 | 68 | 56 | 71 | 79 | 83 | 83 | 89 | 122 | 138 | 179 | 135 | 138 |
| OPM % | 24% | 25% | 19% | 22% | 21% | 18% | 17% | 21% | 17% | 17% | 19% | 12% | 12% |
| Other Income | 2 | 2 | 2 | 7 | 10 | 9 | 17 | 8 | 8 | 22 | 19 | 28 | 22 |
| Interest | 2 | 5 | 10 | 11 | 12 | 9 | 7 | 5 | 8 | 11 | 18 | 41 | 40 |
| Depreciation | 11 | 21 | 11 | 17 | 23 | 33 | 36 | 37 | 43 | 48 | 52 | 66 | 66 |
| Profit before tax | 52 | 43 | 36 | 50 | 54 | 50 | 57 | 55 | 79 | 102 | 128 | 56 | 53 |
| Tax % | 28% | 43% | -1% | 43% | 27% | 37% | 51% | 23% | 32% | 34% | 35% | 97% | |
| Net Profit | 38 | 25 | 36 | 29 | 39 | 32 | 28 | 42 | 54 | 68 | 84 | 2 | -0 |
| EPS in Rs | 11.17 | 7.36 | 4.30 | 3.40 | 3.65 | 2.93 | 2.55 | 3.93 | 5.01 | 6.27 | 7.78 | 0.58 | 0.42 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 17% | 20% | 25% | 20% | 19% | 15% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -34.21% | 44.00% | -19.44% | 34.48% | -17.95% | -12.50% | 50.00% | 28.57% | 25.93% | 23.53% | -97.62% |
| Change in YoY Net Profit Growth (%) | 0.00% | 78.21% | -63.44% | 53.93% | -52.43% | 5.45% | 62.50% | -21.43% | -2.65% | -2.40% | -121.15% |
Shalby Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 16% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | -26% |
| 3 Years: | -52% |
| TTM: | -101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 12% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 1:26 pm
Balance Sheet
Last Updated: December 4, 2025, 1:57 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 35 | 35 | 87 | 87 | 108 | 108 | 108 | 108 | 108 | 107 | 107 | 107 | 108 |
| Reserves | 106 | 133 | 117 | 164 | 643 | 672 | 691 | 727 | 768 | 820 | 893 | 885 | 895 |
| Borrowings | 37 | 98 | 224 | 328 | 114 | 71 | 62 | 44 | 155 | 180 | 378 | 476 | 535 |
| Other Liabilities | 39 | 85 | 75 | 99 | 96 | 89 | 105 | 118 | 162 | 173 | 231 | 241 | 246 |
| Total Liabilities | 217 | 351 | 504 | 679 | 961 | 939 | 967 | 997 | 1,194 | 1,281 | 1,609 | 1,709 | 1,782 |
| Fixed Assets | 130 | 175 | 319 | 323 | 650 | 692 | 672 | 660 | 675 | 685 | 966 | 955 | 976 |
| CWIP | 5 | 91 | 82 | 221 | 47 | 3 | 6 | 8 | 6 | 11 | 15 | 22 | 54 |
| Investments | 0 | 0 | 0 | 0 | 0 | 11 | 28 | 16 | 25 | 146 | 81 | 95 | 87 |
| Other Assets | 81 | 85 | 102 | 134 | 264 | 233 | 260 | 314 | 488 | 440 | 547 | 637 | 665 |
| Total Assets | 217 | 351 | 504 | 679 | 961 | 939 | 967 | 997 | 1,194 | 1,281 | 1,609 | 1,709 | 1,782 |
Below is a detailed analysis of the balance sheet data for Shalby Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 108.00 Cr.. The value appears strong and on an upward trend. It has increased from 107.00 Cr. (Mar 2025) to 108.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 895.00 Cr.. The value appears strong and on an upward trend. It has increased from 885.00 Cr. (Mar 2025) to 895.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 535.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 476.00 Cr. (Mar 2025) to 535.00 Cr., marking an increase of 59.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 246.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 241.00 Cr. (Mar 2025) to 246.00 Cr., marking an increase of 5.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,782.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,709.00 Cr. (Mar 2025) to 1,782.00 Cr., marking an increase of 73.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 976.00 Cr.. The value appears strong and on an upward trend. It has increased from 955.00 Cr. (Mar 2025) to 976.00 Cr., marking an increase of 21.00 Cr..
- For CWIP, as of Sep 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 54.00 Cr., marking an increase of 32.00 Cr..
- For Investments, as of Sep 2025, the value is 87.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 8.00 Cr..
- For Other Assets, as of Sep 2025, the value is 665.00 Cr.. The value appears strong and on an upward trend. It has increased from 637.00 Cr. (Mar 2025) to 665.00 Cr., marking an increase of 28.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,782.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,709.00 Cr. (Mar 2025) to 1,782.00 Cr., marking an increase of 73.00 Cr..
Notably, the Reserves (895.00 Cr.) exceed the Borrowings (535.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 26.00 | -30.00 | -168.00 | -257.00 | -35.00 | 12.00 | 21.00 | 45.00 | -33.00 | -42.00 | -199.00 | -341.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 29 | 40 | 38 | 49 | 64 | 71 | 80 | 53 | 48 | 57 | 59 |
| Inventory Days | 77 | 113 | 119 | 105 | 242 | 1,152 | 1,361 | 1,017 | ||||
| Days Payable | 395 | 462 | 522 | 415 | 606 | 546 | 744 | 377 | ||||
| Cash Conversion Cycle | 21 | 29 | 40 | -280 | -299 | -339 | -239 | -283 | 53 | 654 | 673 | 698 |
| Working Capital Days | 35 | -46 | -26 | -64 | -18 | 57 | 70 | 77 | 74 | 75 | 48 | 56 |
| ROCE % | 22% | 13% | 12% | 9% | 7% | 7% | 7% | 10% | 10% | 11% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal S&P BSE Healthcare ETF | 287 | 0.09 | 0.01 | 287 | 2025-04-22 17:25:21 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.18 | 7.78 | 6.31 | 5.00 | 3.92 |
| Diluted EPS (Rs.) | 0.18 | 7.77 | 6.27 | 5.00 | 3.92 |
| Cash EPS (Rs.) | 6.30 | 12.64 | 10.79 | 8.97 | 7.33 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 92.31 | 93.82 | 86.44 | 81.13 | 77.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 92.31 | 93.82 | 86.44 | 81.13 | 77.28 |
| Revenue From Operations / Share (Rs.) | 101.12 | 86.93 | 75.01 | 64.72 | 39.90 |
| PBDIT / Share (Rs.) | 14.90 | 18.29 | 14.84 | 12.26 | 8.84 |
| PBIT / Share (Rs.) | 8.79 | 13.43 | 10.36 | 8.29 | 5.43 |
| PBT / Share (Rs.) | 5.18 | 11.93 | 9.51 | 7.33 | 5.10 |
| Net Profit / Share (Rs.) | 0.17 | 7.77 | 6.31 | 5.00 | 3.92 |
| NP After MI And SOA / Share (Rs.) | 0.57 | 7.83 | 6.31 | 5.01 | 3.92 |
| PBDIT Margin (%) | 14.73 | 21.04 | 19.78 | 18.93 | 22.15 |
| PBIT Margin (%) | 8.68 | 15.44 | 13.81 | 12.80 | 13.61 |
| PBT Margin (%) | 5.12 | 13.72 | 12.67 | 11.32 | 12.77 |
| Net Profit Margin (%) | 0.17 | 8.94 | 8.40 | 7.72 | 9.83 |
| NP After MI And SOA Margin (%) | 0.57 | 9.00 | 8.41 | 7.74 | 9.83 |
| Return on Networth / Equity (%) | 0.62 | 8.40 | 7.29 | 6.17 | 5.07 |
| Return on Capital Employeed (%) | 7.56 | 11.22 | 10.22 | 8.76 | 6.41 |
| Return On Assets (%) | 0.36 | 5.23 | 5.28 | 4.53 | 4.25 |
| Long Term Debt / Equity (X) | 0.13 | 0.17 | 0.07 | 0.09 | 0.04 |
| Total Debt / Equity (X) | 0.43 | 0.31 | 0.15 | 0.17 | 0.04 |
| Asset Turnover Ratio (%) | 0.65 | 0.64 | 0.59 | 0.62 | 0.42 |
| Current Ratio (X) | 1.45 | 1.71 | 2.66 | 2.61 | 3.32 |
| Quick Ratio (X) | 0.74 | 0.98 | 1.71 | 1.91 | 3.04 |
| Inventory Turnover Ratio (X) | 3.92 | 0.15 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 208.30 | 15.41 | 15.95 | 19.95 | 12.73 |
| Dividend Payout Ratio (CP) (%) | 18.00 | 9.50 | 9.32 | 11.13 | 6.81 |
| Earning Retention Ratio (%) | -108.30 | 84.59 | 84.05 | 80.05 | 87.27 |
| Cash Earning Retention Ratio (%) | 82.00 | 90.50 | 90.68 | 88.87 | 93.19 |
| Interest Coverage Ratio (X) | 4.14 | 12.25 | 17.44 | 22.43 | 26.38 |
| Interest Coverage Ratio (Post Tax) (X) | 1.05 | 6.21 | 8.41 | 10.90 | 12.71 |
| Enterprise Value (Cr.) | 2524.31 | 2864.54 | 1573.71 | 1305.75 | 1041.12 |
| EV / Net Operating Revenue (X) | 2.32 | 3.07 | 1.96 | 1.87 | 2.42 |
| EV / EBITDA (X) | 15.76 | 14.58 | 9.88 | 9.87 | 10.91 |
| MarketCap / Net Operating Revenue (X) | 1.96 | 2.75 | 1.79 | 1.80 | 2.53 |
| Retention Ratios (%) | -108.30 | 84.58 | 84.04 | 80.04 | 87.26 |
| Price / BV (X) | 2.15 | 2.57 | 1.56 | 1.44 | 1.30 |
| Price / Net Operating Revenue (X) | 1.96 | 2.75 | 1.79 | 1.80 | 2.53 |
| EarningsYield | 0.00 | 0.03 | 0.04 | 0.04 | 0.03 |
After reviewing the key financial ratios for Shalby Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 5. It has decreased from 7.78 (Mar 24) to 0.18, marking a decrease of 7.60.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 5. It has decreased from 7.77 (Mar 24) to 0.18, marking a decrease of 7.59.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.30. This value is within the healthy range. It has decreased from 12.64 (Mar 24) to 6.30, marking a decrease of 6.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 92.31. It has decreased from 93.82 (Mar 24) to 92.31, marking a decrease of 1.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 92.31. It has decreased from 93.82 (Mar 24) to 92.31, marking a decrease of 1.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 101.12. It has increased from 86.93 (Mar 24) to 101.12, marking an increase of 14.19.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 14.90. This value is within the healthy range. It has decreased from 18.29 (Mar 24) to 14.90, marking a decrease of 3.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.79. This value is within the healthy range. It has decreased from 13.43 (Mar 24) to 8.79, marking a decrease of 4.64.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.18. This value is within the healthy range. It has decreased from 11.93 (Mar 24) to 5.18, marking a decrease of 6.75.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 2. It has decreased from 7.77 (Mar 24) to 0.17, marking a decrease of 7.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 2. It has decreased from 7.83 (Mar 24) to 0.57, marking a decrease of 7.26.
- For PBDIT Margin (%), as of Mar 25, the value is 14.73. This value is within the healthy range. It has decreased from 21.04 (Mar 24) to 14.73, marking a decrease of 6.31.
- For PBIT Margin (%), as of Mar 25, the value is 8.68. This value is below the healthy minimum of 10. It has decreased from 15.44 (Mar 24) to 8.68, marking a decrease of 6.76.
- For PBT Margin (%), as of Mar 25, the value is 5.12. This value is below the healthy minimum of 10. It has decreased from 13.72 (Mar 24) to 5.12, marking a decrease of 8.60.
- For Net Profit Margin (%), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 5. It has decreased from 8.94 (Mar 24) to 0.17, marking a decrease of 8.77.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 8. It has decreased from 9.00 (Mar 24) to 0.57, marking a decrease of 8.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 15. It has decreased from 8.40 (Mar 24) to 0.62, marking a decrease of 7.78.
- For Return on Capital Employeed (%), as of Mar 25, the value is 7.56. This value is below the healthy minimum of 10. It has decreased from 11.22 (Mar 24) to 7.56, marking a decrease of 3.66.
- For Return On Assets (%), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 5. It has decreased from 5.23 (Mar 24) to 0.36, marking a decrease of 4.87.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.17 (Mar 24) to 0.13, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has increased from 0.31 (Mar 24) to 0.43, marking an increase of 0.12.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.65. It has increased from 0.64 (Mar 24) to 0.65, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 1.5. It has decreased from 1.71 (Mar 24) to 1.45, marking a decrease of 0.26.
- For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.74, marking a decrease of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.92. This value is below the healthy minimum of 4. It has increased from 0.15 (Mar 24) to 3.92, marking an increase of 3.77.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 208.30. This value exceeds the healthy maximum of 50. It has increased from 15.41 (Mar 24) to 208.30, marking an increase of 192.89.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 18.00. This value is below the healthy minimum of 20. It has increased from 9.50 (Mar 24) to 18.00, marking an increase of 8.50.
- For Earning Retention Ratio (%), as of Mar 25, the value is -108.30. This value is below the healthy minimum of 40. It has decreased from 84.59 (Mar 24) to -108.30, marking a decrease of 192.89.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 82.00. This value exceeds the healthy maximum of 70. It has decreased from 90.50 (Mar 24) to 82.00, marking a decrease of 8.50.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.14. This value is within the healthy range. It has decreased from 12.25 (Mar 24) to 4.14, marking a decrease of 8.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 3. It has decreased from 6.21 (Mar 24) to 1.05, marking a decrease of 5.16.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,524.31. It has decreased from 2,864.54 (Mar 24) to 2,524.31, marking a decrease of 340.23.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.32. This value is within the healthy range. It has decreased from 3.07 (Mar 24) to 2.32, marking a decrease of 0.75.
- For EV / EBITDA (X), as of Mar 25, the value is 15.76. This value exceeds the healthy maximum of 15. It has increased from 14.58 (Mar 24) to 15.76, marking an increase of 1.18.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.75 (Mar 24) to 1.96, marking a decrease of 0.79.
- For Retention Ratios (%), as of Mar 25, the value is -108.30. This value is below the healthy minimum of 30. It has decreased from 84.58 (Mar 24) to -108.30, marking a decrease of 192.88.
- For Price / BV (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has decreased from 2.57 (Mar 24) to 2.15, marking a decrease of 0.42.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.75 (Mar 24) to 1.96, marking a decrease of 0.79.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.00, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Shalby Ltd:
- Net Profit Margin: 0.17%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 7.56% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.62% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.74
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 433 (Industry average Stock P/E: 90.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.17%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | Shalby Multi-Specialty Hospitals, Opp. Karnavati Club, Ahmedabad Gujarat 380015 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Vikram Shah | Chairman & Managing Director |
| Dr. Ashok Bhatia | Independent Director |
| CA. Shyamal Joshi | Independent Director |
| Dr. Umesh Menon | Independent Director |
| Mr. Tej Malhotra | Independent Director |
| CA. Sujana Shah | Independent Director |
| Mr. Vijay Kedia | Independent Director |
FAQ
What is the intrinsic value of Shalby Ltd?
Shalby Ltd's intrinsic value (as of 17 January 2026) is ₹123.82 which is 31.21% lower the current market price of ₹180.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,941 Cr. market cap, FY2025-2026 high/low of ₹275/177, reserves of ₹895 Cr, and liabilities of ₹1,782 Cr.
What is the Market Cap of Shalby Ltd?
The Market Cap of Shalby Ltd is 1,941 Cr..
What is the current Stock Price of Shalby Ltd as on 17 January 2026?
The current stock price of Shalby Ltd as on 17 January 2026 is ₹180.
What is the High / Low of Shalby Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Shalby Ltd stocks is ₹275/177.
What is the Stock P/E of Shalby Ltd?
The Stock P/E of Shalby Ltd is 433.
What is the Book Value of Shalby Ltd?
The Book Value of Shalby Ltd is 92.8.
What is the Dividend Yield of Shalby Ltd?
The Dividend Yield of Shalby Ltd is 0.00 %.
What is the ROCE of Shalby Ltd?
The ROCE of Shalby Ltd is 6.12 %.
What is the ROE of Shalby Ltd?
The ROE of Shalby Ltd is 0.62 %.
What is the Face Value of Shalby Ltd?
The Face Value of Shalby Ltd is 10.0.